Press release
Page 1
XVIVO XVIVO Capital Markets Day presents strategic focus areas for 2022-2026 PRESSMEDDELANDE 23 september 2021 Göteborg At the XVIVO Capital Markets Day in Gothenburg , Sweden today , CEO Dag Andersson and other senior executives will focus on the company's strategy to become the world leader in the transplant industry . XVIVO will present five strategic focus areas for the period 2022 – 2026 ; Global leader Abdominal ( with initial focus on the US ) ; Market leading heart preservation system ; Increase penetration of machine perfusion ; Secure all - inclusive reimbursement in key geographic areas ; and China to become the company ' s second largest market . " Strategy is about making choices and about deliberately choosing to be different , and always for us considering our overall vision that nobody should die waiting for a new organ . With our five strategic focus areas we have defined our way forward and the keys to our future success " says Dag Andersson , CEO . During the Capital Markets Day , financial targets and the actions to reach these targets will be presented . XVIVOS ambition is to reach an EBIT - margin of 20 % and an EBITDA - margin of 30 % during the strategy period . In 2026 , Abdominal revenue is expected to be of equal size as Thoracic revenue . XVIVO will continue to build on its world leading position in lung transplantation and develop the offering to cover all four major organs : lung , heart , kidney and liver . The Capital Markets Day will be broadcasted live online today , on 23 September 2021 , at 13:00 CEST via this link : https://xvivo.creo.se/210923 . A recording of the Capital Markets Day will be available on demand shortly after the event via the same link . Gothenburg , September 23 För ytterligare information , vänligen kontakta : Kristoffer Nordström , CFO & IR , +46 735 192 164 , e - post : kristoffer.nordstrom@xvivogroup.com Anne Lycke , Executive Assistant , +46 735 192 146 , e - post : anne.lycke@xvivogroup.com XVIVO Perfusion AB , Box 530 15 , SE - 400 14 Göteborg . Org . Nr . 556561-0424 . Tel : 031-788 21 50. Fax : 031-788 21 69. E mail : info@xvivoperfusion.com . Hemsida : www.xvivoperfusion.com